GLP-1 Receptor Agonists: Balancing Benefits and...

By João L. Carapinha

January 13, 2025

A recent study highlighted several key points on the benefits and risks associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) and the importance of individualized treatment decisions. The risks of GLP-1RAs, especially their associat...